Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy

Richard E. Pratley, M. S. Kipnes, P. R. Fleck, C. Wilson, Q. Mekki, P. Castano, J. Cuadrado, L. Maffei, F. Massari, G. Sposetti, M. Ulla, S. Colagiuri, M. dEmden, D. O'Neal, J. Prins, A. Roberts, M. Dinato, A. Forti, J. Gross, C. HayashidaJ. Neto, R. Rea, L. Aguirre, G. Gonzalo, F. Munizaga, F. Luna-Sevez, A. Granandos-Fuentes, L. Ramirez-Roca, F. Sanchez-Morales, K. Prasanna Kumar, N. Rais, V. Seshiah, N. Thomas, M. Viswanathan, V. Viswanathan, C. Dueñas-Garcia, G. Gonzalez-Galvez, C. Gonzalez-Villalpando, F. Mar-Arevalo, E. Morales-Villegas, F. Salinas-Gonzalez, A. Dees, A. Deijl, A. Dissanayake, J. Krebs, R. Scott, S. Young, H. Arbañil, S. Corigliano, L. Gonzales, A. Luna, G. Molina, L. More, J. Kuleta, J. Loba, P. Mader, A. Mikolajczyk-Swatko, J. Sawer-Szewczyk, A. Stankiewicz, Z. Stepien, W. Boyd, L. Burgess, G. Ellis, P. Joshi, L. De Teresa, T. Hall, C. McKinnon, J. Ryan, J. Barrera, G. Bonabi, C. Chappel, W. Cheatham, L. Cohen, C. Corder, S. Elliott, D. Fitz-Patrick, M. Hassman, P. Hollander, D. Hurley, C. Jones, M. Kipnes, W. Koppel, S. Landgarten, A. Lewin, M. Lindley, R. Lipetz, T. Littlejohn, J. Lucas, G. Mark, R. Marple, E. Mattson, S. Mayeda, M. McAdoo, D. Morin, J. Mullen, J. Neutel, P. Norwood, S. Oates, A. Odugbesan, R. Pratley, K. Pudi, M. Rendell, K. Rock, J. Rosenstock, K. Sall, D. Santram, M. Seidner, T. Smith, M. Soboeiro, J. Sparks, R. Stegemoller, L. Taber, H. Wadsworth, J. Wahle, R. Weinstein, J. Wilker

Research output: Contribution to journalArticle

126 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences